INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $458,000 | +6.5% | 35,278 | 0.0% | 0.08% | +21.4% |
Q1 2019 | $430,000 | +7.0% | 35,278 | 0.0% | 0.07% | -6.7% |
Q4 2018 | $402,000 | -47.5% | 35,278 | 0.0% | 0.08% | -39.0% |
Q3 2018 | $766,000 | +23.0% | 35,278 | 0.0% | 0.12% | +28.1% |
Q2 2018 | $623,000 | -16.2% | 35,278 | 0.0% | 0.10% | -21.3% |
Q1 2018 | $743,000 | +45.4% | 35,278 | 0.0% | 0.12% | +56.4% |
Q4 2017 | $511,000 | – | 35,278 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |